Cited 20 time in
Topology dependent modification of layered double hydroxide for therapeutic and diagnostic platform
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Tae-Hyun | - |
| dc.contributor.author | Lee, Jun Young | - |
| dc.contributor.author | Xie, Jing | - |
| dc.contributor.author | Park, Jeong Hoon | - |
| dc.contributor.author | Oh, Jae-Min | - |
| dc.date.accessioned | 2023-04-27T09:40:54Z | - |
| dc.date.available | 2023-04-27T09:40:54Z | - |
| dc.date.issued | 2022-09 | - |
| dc.identifier.issn | 0169-409X | - |
| dc.identifier.issn | 1872-8294 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/2631 | - |
| dc.description.abstract | Layered double hydroxide is a family of two-dimensional materials with wide range of compositions. Recently, its ability to accommodate various chemical species and biocompatibility have been attracted in the biomedical applications to develop drug delivery system and nanodiagnostics. In this review, we categorized biomedical approaches of layered double hydroxide with respect to the three topologies of, namely, interlayer space, outer surface with particle edge, and the lattice points. There have been extensive researches on the intercalation of drug or tracing to make use of interlayer space of layered double hydroxide for drug stabilization, sustained release, cellular delivery and etc. Outer surface or edge has been utilized to immobilization of large therapeutic moieties and to attach tracing moiety. Lattice points consisting of various metal species could be utilized for the specific metal species like paramag-netic elements or radioisotopes. Based on these topologies in layered double hydroxide, both the syn-thetic routes and the achieved functionalities in terms of biomedical application will be discussed.(c) 2022 Elsevier B.V. All rights reserved. | - |
| dc.format.extent | 23 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Elsevier | - |
| dc.title | Topology dependent modification of layered double hydroxide for therapeutic and diagnostic platform | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.addr.2022.114459 | - |
| dc.identifier.scopusid | 2-s2.0-85134887626 | - |
| dc.identifier.wosid | 000853361900002 | - |
| dc.identifier.bibliographicCitation | Advanced Drug Delivery Reviews, v.188, pp 1 - 23 | - |
| dc.citation.title | Advanced Drug Delivery Reviews | - |
| dc.citation.volume | 188 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 23 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | CONTROLLED-RELEASE PROPERTIES | - |
| dc.subject.keywordPlus | DRUG-DELIVERY SYSTEM | - |
| dc.subject.keywordPlus | IN-VITRO | - |
| dc.subject.keywordPlus | PHOTODYNAMIC THERAPY | - |
| dc.subject.keywordPlus | CELLULAR UPTAKE | - |
| dc.subject.keywordPlus | ION-EXCHANGE | - |
| dc.subject.keywordPlus | INTRACRYSTALLINE STRUCTURE | - |
| dc.subject.keywordPlus | THERANOSTIC NANOPLATFORM | - |
| dc.subject.keywordPlus | COLLOIDAL STABILITY | - |
| dc.subject.keywordPlus | CANCER-THERAPY | - |
| dc.subject.keywordAuthor | Layered double hydroxide | - |
| dc.subject.keywordAuthor | Intercalation | - |
| dc.subject.keywordAuthor | Surface | - |
| dc.subject.keywordAuthor | Lattice | - |
| dc.subject.keywordAuthor | Biomedical | - |
| dc.subject.keywordAuthor | Drug delivery | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
